Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ru Cat. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115710227B reveals Ru-catalyzed synthesis enabling cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain continuity.
Patent CN112209876B details a Ru-catalyzed route for high-purity isoquinolinones. Discover cost-effective manufacturing and scalable supply chain solutions for pharma intermediates.
Patent CN115286609B reveals a ruthenium-catalyzed route for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Novel ruthenium-catalyzed route offers high yield and scalability for pharmaceutical intermediates manufacturing with enhanced safety.
Novel Ru-catalyzed transfer hydrogenation method for 3-acylpyrroles. High atom economy, scalable process for reliable pharmaceutical intermediate supply and cost reduction.
Patent CN109651421B details a cost-effective Ru-catalyzed C-H silylation. Offers high yields up to 85% for pharmaceutical intermediates, ensuring reliable supply chain stability.
Patent CN107973691A reveals Ru-catalyzed synthesis for high-purity naphthalene derivatives. Enables cost reduction in electronic chemical manufacturing and scalable supply.
Patent CN115286609B reveals a ruthenium-catalyzed route for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN112920053B details a mild, high-yield route for chiral amines used in asthma and oncology drugs, offering significant supply chain stability.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN105732619B details a ruthenium-catalyzed one-step synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel Ru-catalyzed aqueous synthesis of distyryl indoles offers high yield and eco-friendly processing for pharmaceutical intermediates.
Patent CN107973778B details Ru-catalyzed synthesis for optoelectronic and pharma use. Offers green, scalable production without oxidants for reliable supply chains.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Patent CN113636968B details a Ru-catalyzed route to 3-acylpyrroles. Offers cost reduction in API manufacturing and high atom economy for pharma intermediates.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN115286609B reveals efficient ruthenium-catalyzed route. Enables high-purity pharmaceutical intermediates with reduced operational risks and scalable production capabilities.
Novel ruthenium-catalyzed C-H silylation method offers cost-effective production of high-purity pharmaceutical intermediates with simplified one-pot processing.
Patent CN102153434B details a cost-effective ruthenium catalyzed method for preparing aryl ketones from aldehydes and boronic acids, offering significant supply chain advantages.